NCT07175857View on ClinicalTrials.gov

Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis

NARecruitingINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

July 21, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Endometriosis
Interventions
DEVICE

Lyv Endo app

Lyv Endo is a CE-marked Class I therapeutic digital medical device offering a patient-centered, integrative approach. Its innovation lies in its ability to deliver personalized content based on symptoms, surpassing the limits of traditional care.

Trial Locations (6)

33000

RECRUITING

Clinique Tivoli Ducos, Bordeaux

44600

NOT_YET_RECRUITING

Centre Hospitalier de Saint Nazaire, Saint-Nazaire

59000

RECRUITING

Hôpital Le Blois, Lille

72000

NOT_YET_RECRUITING

Centre Hospitalier Le Mans, Le Mans

75014

RECRUITING

Hôpital Paris Saint-Joseph, Paris

78157

RECRUITING

Centre Hospitalier de Versailles, Le Chesnay

Sponsors

Lead Sponsor

Lyv Healthcare
All Listed Sponsors
lead

Lyv Healthcare

INDUSTRY

NCT07175857 - Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis | Biotech Hunter | Biotech Hunter